Influential Chemist Dies

Carl Djerassi, who synthesized a hormone that was key to the creation of the birth control pill, has passed away at age 91.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Carl Djerassi in 2004WIKIMEDIA, CHEMICAL HERITAGE FOUNDATIONBest known for his contribution to the development of oral birth control, chemist Carl Djerassi died last week (January 30) of complications from cancer. He was 91.

After earning an undergraduate degree from Kenyon College in Ohio, Djerassi received a PhD from the University of Wisconsin-Madison in 1945. He then joined pharmaceutical company Ciba (now Novartis) before moving to drugmaker Syntex in Mexico City, where he made his pioneering discoveries on cortisone, menstrual disorders, and cancer, The New York Times (NYT) reported.

“Yes, I am proud to be called the father of the pill,” Djerassi told The Guardian in August 2000 (via NYT). “But identifying scientists is really only a surrogate for identifying the inventions or discoveries. Maybe it is true that Shakespeare’s plays would never have been written if it wasn’t for Shakespeare. But I’m certain that if we didn’t do our work, then someone else would have come along shortly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies